← Open Payments lookup

MELISSA FRANCO: Open Payments

NPI 1801161559 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,165 in 37 payments from 11 companies in 2025. Trend: 2023 $1,932 · 2024 $4,551 · 2025 $4,165

Consulting: $2,130Food & beverage: $1,503Speaker / faculty: $500Education: $32
CompanyPaymentsAmount
Madrigal Pharmaceuticals5$1,361
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$740
Ipsen Biopharmaceuticals, Inc7$670
Gilead Sciences, Inc.9$604
GlaxoSmithKline, LLC.2$500
Novo Nordisk Inc2$60
Aimmune Therapeutics, Inc.2$59
Intercept Pharmaceuticals, Inc.2$57
Inspire Medical Systems, Inc.1$48
Phathom Pharmaceuticals, Inc.1$37

Products named: REZDIFFRA, XIFAXAN, IQIRVO, ZENPEP, OCALIVA, INSPIRE, VOQUEZNA, TREMFYA.

Industry payments across FL — which companies pay providers there.